Case Detail

Friedman v. Sebelius
On July 27, 2012, a federal appeals court largely upheld draconian penalties imposed on three pharmaceutical executives after they pled guilty to misdemeanor charges under the “responsible corporate officer” (RCO) doctrine. The decision was a setback for WLF, which filed a brief urging that the penalties be set aside. WLF charged that federal officials who imposed the penalties misconstrued the limited nature of the RCO doctrine. The appeals court ruled 2-1 that the executives were properly excluded from the health care field under a statutes that permits exclusion of those convicted of a “misdemeanor relating to fraud.” Although the executives were not accused of fraud – indeed, the prosecutor who filed the RCO charges conceded that they had no knowledge of improper drug promotion that occurred at their company – the court held exclusion was permissible because there was at least some relationship between the executive’s supervisory responsibilities and the underlying misconduct.
Case Status:
Loss. Monitoring for further appeals.
More Information and Downloads:
6/29/2011: Download the Brief
3/22/2010: Download the Brief
3/26/2009: Download the Brief

  • Welcome to the Washington Legal Foundation
  • 2009 Massachusetts Ave., NW
    Washington, DC 20036
  • info@wlf.org  |  ph. 202-588-0302
    ©2018 WLF All Rights Reserved